With the sequencing of the human genome, the question of patenting genes has become front page news. To shed some light on the controversial topic, MIP assembled seven biotech specialists at Taylor Joynson Garrett's offices in London, with telephone and video-links to the US. The wide-ranging debate covered utility, ESTs, examination standards, the role of patents and ethical objections. Chuck Ludlam begins the discussion
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
UK firm Shakespeare Martineau, which secured victory for the Triton shower brand at the Court of Appeal, explains how it navigated a tricky test regarding patent claim scopes